Organon & Co
NYSE:OGN

Watchlist Manager
Organon & Co Logo
Organon & Co
NYSE:OGN
Watchlist
Price: 8.13 USD -0.73% Market Closed
Market Cap: 2.1B USD

Relative Value

The Relative Value of one OGN stock under the Base Case scenario is hidden USD. Compared to the current market price of 8.13 USD, Organon & Co is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

OGN Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
91
vs Industry
80
Median 3Y
0.7
Median 5Y
0.8
Industry
2.6
Forward
0.3
vs History
65
vs Industry
43
Median 3Y
4.6
Median 5Y
4.9
Industry
21.4
Forward
2.1
vs History
89
vs Industry
49
Median 3Y
5
Median 5Y
4.8
Industry
16.4
vs History
53
vs Industry
2
Median 3Y
10
Median 5Y
7.8
Industry
22.8
vs History
32
vs Industry
8
Median 3Y
2.3
Median 5Y
-4.1
Industry
2.2
vs History
89
vs Industry
52
Median 3Y
2
Median 5Y
2.1
Industry
2.9
Forward
1.6
vs History
89
vs Industry
57
Median 3Y
3.3
Median 5Y
3.5
Industry
5.5
vs History
89
vs Industry
41
Median 3Y
7.3
Median 5Y
7.2
Industry
13
Forward
5.2
vs History
81
vs Industry
40
Median 3Y
8.6
Median 5Y
8.2
Industry
16.5
Forward
5.9
vs History
74
vs Industry
32
Median 3Y
13.5
Median 5Y
13.2
Industry
15.6
vs History
68
vs Industry
22
Median 3Y
22.2
Median 5Y
20.6
Industry
18.7
vs History
91
vs Industry
55
Median 3Y
1.2
Median 5Y
1.3
Industry
1.9

Multiples Across Competitors

OGN Competitors Multiples
Organon & Co Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Organon & Co
NYSE:OGN
2.1B USD 0.3 4.2 6 7.5
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.3 55.7 37.4 40.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
495.1B USD 5.4 19.7 16.1 20.9
CH
Roche Holding AG
SIX:ROG
270.3B CHF 4.4 28.7 12.2 14.2
UK
AstraZeneca PLC
LSE:AZN
219.8B GBP 5.1 31.4 108.8 159.2
US
Merck & Co Inc
NYSE:MRK
276.1B USD 4.3 14.5 10.3 12.2
CH
Novartis AG
SIX:NOVN
218.3B CHF 4.9 19 12 15.5
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK 5.2 15.8 11 12.8
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
143.8B USD 2.3 14.6 7.5 10.2
P/E Multiple
Earnings Growth PEG
US
Organon & Co
NYSE:OGN
Average P/E: 22.6
4.2
7%
0.6
US
Eli Lilly and Co
NYSE:LLY
55.7
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.7
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.7
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.4
37%
0.8
US
Merck & Co Inc
NYSE:MRK
14.5
15%
1
CH
Novartis AG
SIX:NOVN
19
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
15.8
3%
5.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Organon & Co
NYSE:OGN
Average EV/EBITDA: 400.6
6
5%
1.2
US
Eli Lilly and Co
NYSE:LLY
37.4
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.1
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.2
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.8
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10.3
6%
1.7
CH
Novartis AG
SIX:NOVN
12
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
11
1%
11
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Organon & Co
NYSE:OGN
Average EV/EBIT: 1 713.1
7.5
7%
1.1
US
Eli Lilly and Co
NYSE:LLY
40.1
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.9
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.2
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.2
23%
6.9
US
Merck & Co Inc
NYSE:MRK
12.2
8%
1.5
CH
Novartis AG
SIX:NOVN
15.5
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
12.8
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5